Summary
General Reviews
The impact of HSC on the cardiovascular system is the target of numerous studies lately, given that thyroid hormones have multiple actions on the heart and the vascular system. 
Definition
Subclinical hypothyroidism, the early form of thyroid insufficiency, is characterized by mild deficiency of thyroid hormones and its identification is possible due to the increase in the current performance of thyroid functional tests . Most authors define HSC (2) by the isolated increase in serum TSH (thyroid stimulating hormone) > 4-6 mIU/L in the presence of normal levels of FT4 (free thyroxine) and T3 (triiodothyronine) . (2, 3, 4, 5) However, the exact definition and clinical significance of HSC is confronted with controversy over the correct upper limit of the baseline of serum TSH. A classification of HSC in mild and severe form is also attempted, depending on the serum TSH elevation:
l medium form -TSH 4.5-9 mU/I l severe form -TSH ≥ 10 mU/I.
Etiology
The most common cause of HSC (60-80%) is chronic autoimmune thyroiditis associated with the presence of anti-thyroid antibodies (anti-thyroid peroxidase antibodies -ATPO), which are characteristics of chronic lymphocytic Hashimoto thyroiditis . This is (3) more common in women, but the incidence increases with age for both sexes .
(
Increased titre of thyroid auto antibodies and / or serum TSH >6 mI/L are solid arguments for the diagnosis of the disease and indicate p o s s i b l e p r o g r e s s i o n t o m a n i f e s t hypothyroidism.
Other causes of HSC can be : (1) l inappropriate substitution treatment for manifest thyroid insufficiency; ( 1 ) relatively high, in 4-15% of the general population, with older, elderly and deficient iodine being higher, up to 20%. The (5, 6, 8, 9) average form can be found in approximately 75% of HSC patients. (2) have shown that TSH level 1-1.9 mIU/I indicates the lowest thyroid dysfunction s c o re a n d T S H i n c re a s e > 2 m I U / I i s associated with an increase in hypothyroidism . HSD may persist for years or may (3) develop into myxoedema, especially in persons with autoimmune thyroidism and high titre of thyroid autoantibodies The risk (4) of progression to manifest hypothyroidism this association is unclear, but generic studies have described some gene polymorphisms in these patients . (16, 17, 18) l Endothelial dysfunction, one of the early signs of sclerosis, has been observed in HSC . Numerous multicenter studies (19, 20, 21) have indicated an increased risk of atherosclerosis in people with HSC.
Multiple lipid plaques in the large artery wall have been identified in patients with HSC, comparable to those seen in the elderly with other risk factors such as hypercholesterolemia, hypertension, smoking and diabetes. Also, the incidence of myocardial infarction or congestive heart failure has been increased in the elderly with TSH > 7mU/I . In (22, 23, 24, 25) manifest or subclinical hypothyroidism, 
Cardiovascular disease in subclinical hypothyroidism
Thyroid deficiency is associated with HTA, atherosclerosis / coronary artery disease, heart failure and increased cardiovascular mortality . The elevated level of TSH (22, 23, 24, 25) plays an important role in the mechanisms t h a t i n d u c e a t h e ro s c l e ro s i s a n d i t s progression : (28) l hyperlipaemia, oxidative stress, chronic inflammation, insulin resistance; treatment . (35, 36, 37) Relationship between serum TSH and HTA
The prevalence of HTA in HSC is significantly higher than in the elderly, and the HTA risk was significantly higher after correction of age, sex, smoking, the HOMA-IR (homeostatis modem assessment of insulin resistance) index and BMI (body mass index). The increase in TA in hypothyroidism is explained by multiple mechanisms : (38, 39) l increased systemic vascular resistance attributed in part to decreased T3 (T3 produces vasodilatation by direct action on smooth muscle cells); it has also been shown that increased TSH favors the proliferation of vascular smooth muscle cells and endothelial dysfunction ; (40, 41) l abnormalities in sodium metabolism;
l increased levels of catecholamines and SN Simpatic activity;
l decrease in glomerular filtration rate and increase in total water and salt content;
l TA sensitivity to salt-mediated, in part, by vascular action of T3.
l increased risk of atherosclerosis due to associated anomalies: hypercoagulability, increased blood viscosity, lipid abnormalities; in this way, hypothyroidism also influences TA . (42, 43) Pericarditis may be common in hypothy- r e s i s t a n c e / g l u c o s e i n t o l e r a n c e , dyslipidemia, hypertension and is associated with increased cardiovascular risk and mortality. Numerous population studies have observed the association of metabolic syndrome with HSC . The imbalance (44, 45) between the hypothalamus, pituitary, thyroid, and adipose tissue is responsible for the pathophysiological mechanisms of HSC association with obesity in metabolic syndrome . The association of subclinical (46) hypothyroidism 
The intimate mechanism of altering thyroid function in obesity was linked to the adaptation to increased energy consumption of obesity, and the increase in TSH was explained by multiple mechanisms : (48) l HSC produced by iodine deficiency;
l autoimmune thyroiditis; 
